Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 224 - 226 |
| Number of pages | 3 |
| Journal | American Journal of Respiratory and Critical Care Medicine |
| Volume | 187 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2013 |
Cite this
}
Extracorporeal membrane oxygenation rescue for H1N1 acute respiratory distress syndrome: equipoise regained. / Cooper, David James; Hodgson, Carol Lynette.
In: American Journal of Respiratory and Critical Care Medicine, Vol. 187, No. 3, 2013, p. 224 - 226.Research output: Contribution to journal › Letter › Other
TY - JOUR
T1 - Extracorporeal membrane oxygenation rescue for H1N1 acute respiratory distress syndrome: equipoise regained
AU - Cooper, David James
AU - Hodgson, Carol Lynette
PY - 2013
Y1 - 2013
N2 - In this issue of the Journal, Pham and colleagues (pp. 276?285) report patient outcomes after extracorporeal membrane oxygenation (ECMO) as a rescue therapy for acute respiratory distress syndrome (ARDS) during the 2009?2011 H1N1 influenza pandemic (1). Patients who received ECMO were compared with largely concurrent patients with H1N1 ARDS who did not have ECMO, by matching patient characteristics using propensity scoring. The pandemic timing did not permit a randomized controlled trial, but it provided a unique opportunity to study a substantial sample of patients receiving venovenous ECMO for ARDS in France from a single etiology. The REVA investigators are to be congratulated for building the impressive collaborative national network of clinician-investigators that enabled this research.
AB - In this issue of the Journal, Pham and colleagues (pp. 276?285) report patient outcomes after extracorporeal membrane oxygenation (ECMO) as a rescue therapy for acute respiratory distress syndrome (ARDS) during the 2009?2011 H1N1 influenza pandemic (1). Patients who received ECMO were compared with largely concurrent patients with H1N1 ARDS who did not have ECMO, by matching patient characteristics using propensity scoring. The pandemic timing did not permit a randomized controlled trial, but it provided a unique opportunity to study a substantial sample of patients receiving venovenous ECMO for ARDS in France from a single etiology. The REVA investigators are to be congratulated for building the impressive collaborative national network of clinician-investigators that enabled this research.
UR - http://www.atsjournals.org/doi/abs/10.1164/rccm.201211-2052ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
U2 - 10.1164/rccm.201211-2052ED
DO - 10.1164/rccm.201211-2052ED
M3 - Letter
VL - 187
SP - 224
EP - 226
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
SN - 1073-449X
IS - 3
ER -